Sermorelin (GHRH 1-29)

Precision Growth Hormone-Releasing Hormone Analogue

Executive Overview

Sermorelin, also designated as GHRH (1-29), is a highly refined synthetic peptide representing the shortest functional fragment of the naturally occurring human Growth Hormone-Releasing Hormone. It consists of the first 29 amino acids of the N-terminal segment, which is the specific region responsible for biological activity and receptor binding.

Unlike exogenous human growth hormone (hGH) therapy, Sermorelin acts as a secretagogue, encouraging the endocrine system to produce its own hormones, thereby maintaining the integrity of the hypothalamic-pituitary-somatotropic axis.

Advanced Mechanism of Action

Sermorelin operates by binding directly to the Growth Hormone-Releasing Hormone Receptor (GHRHR) located on the somatotroph cells of the anterior pituitary gland.

Key Physiological Distinctiveness:

• Pulsatile Secretion: Sermorelin preserves the body’s natural, rhythmic “pulses” of growth hormone release. This prevents the downregulation of receptors often seen with constant, high-level administration of exogenous hormones.

• Negative Feedback Loop: Because it relies on the pituitary’s internal capacity, it is subject to the body’s natural feedback mechanisms (via somatostatin), which inherently limits the risk of excessive GH levels.

• IGF-1 Modulation: Its activity triggers the liver to produce Insulin-like Growth Factor 1 (IGF-1), the primary mediator of the growth-promoting effects of GH on bone and muscle tissue.

Research & Laboratory Applications

In various research models, Sermorelin is utilized to investigate the following biological impacts:

• Metabolic Regulation: Analysis of enhanced lipolysis (the breakdown of adipose tissue) and nutrient partitioning.

• Tissue Repair: Investigation into increased protein synthesis and the promotion of lean muscle mass development.

• Diagnostic Utility: Serving as a gold-standard agent for assessing pituitary reserve and somatotropic function.

• Circadian Biology: Research into the correlation between GHRH analogues and the improvement of deep-wave sleep cycles.

Chemical & Physical Specifications

Storage & Handling Protocols

To ensure the stability of the 29-amino-acid chain:

• Long-Term Storage: Store lyophilized powder at -20°C for maximum shelf life.

• Reconstitution: Dissolve in a suitable sterile diluent (e.g., Bacteriostatic Water). Once reconstituted, store strictly at 2°C to 8°C.

• Integrity Note: Avoid exposure to excessive heat or light. Do not shake the vial vigorously after reconstitution to prevent peptide denaturation.

Strict Laboratory Disclaimer

FOR RESEARCH USE ONLY: This product is intended strictly for in vitro laboratory analysis and scientific investigation. It is not intended for human or veterinary consumption, medical diagnosis, or therapeutic use. Handle in accordance with institutional safety and ethical guidelines.